hydroxychloroquine
Jump to
55 Results Found
  • Coronavirus pandemic | United Kingdom approves resumption of hydroxychloroquine trial Jun 30, 2020 04:45 PM IST

    Coronavirus pandemic | United Kingdom approves resumption of hydroxychloroquine trial

    The Medicines and Healthcare Products Regulatory Agency had suspended enrollment into the trial after a paper was published in the journal Lancet last month that suggested there was an increased death risk linked to the drug. The paper was found to be based on fraudulent data and was retracted.

  • Why India needs to reassess use of HCQ for COVID-19 treatment Jun 21, 2020 01:41 PM IST

    Why India needs to reassess use of HCQ for COVID-19 treatment

    India has been using hydroxychloroquine, commonly known as HCQ, for treatment of COVID-19 patients and as prophylactic in high-risk groups such as healthcare and other frontline workers.

  • US stockpile stuck with 66 million doses of hydroxychloroquine: Report Jun 18, 2020 10:18 PM IST

    US stockpile stuck with 66 million doses of hydroxychloroquine: Report

    The FDA on June 15 withdrew the EUA for Chloroquine Phosphate (CQ) and Hydroxychloroquine Sulfate (HCQ), as it no longer believes the drugs may be effective in treating COVID-19 and that their side-effects may outweigh any potential benefit.

  • WHO halts trial of hydroxychloroquine in COVID-19 patients Jun 18, 2020 08:40 AM IST

    WHO halts trial of hydroxychloroquine in COVID-19 patients

    "The hydroxychloroquine arm of the SOLIDARITY trial has been stopped," WHO expert Ana Maria Henao-Restrepo told a news briefing.

  • Coronavirus pandemic | USFDA revokes emergency use status of hydroxychloroquine drug touted by Trump for COVID-19 Jun 15, 2020 09:55 PM IST

    Coronavirus pandemic | USFDA revokes emergency use status of hydroxychloroquine drug touted by Trump for COVID-19

    US FDA revoked the authorization following a request from Gary Disbrow, acting director of the Biomedical Advanced Research and Development Authority (BARDA).

  • Hydroxychloroquine should be avoided in severe cases: Health Ministry Jun 13, 2020 09:17 PM IST

    Hydroxychloroquine should be avoided in severe cases: Health Ministry

    Hydroxychloroquine has demonstrated in-vitro activity against SARS-CoV2 and was shown to be clinically beneficial in several small single-centre studies though with significant limitations, it stated.

  • Remdesivir, tocilizumab being considered for 'restricted use' on severely ill COVID-19 patients Jun 11, 2020 05:41 PM IST

    Remdesivir, tocilizumab being considered for 'restricted use' on severely ill COVID-19 patients

    The much-touted anti-malarial drug hydroxychloroquine will continue to be used while azythromycin may be dropped from the treatment protocol, sources in the know of the developments told PTI.

  • India lifts export ban on Trump-touted drug hydroxychloroquine Jun 11, 2020 11:47 AM IST

    India lifts export ban on Trump-touted drug hydroxychloroquine

    "Department of Pharmaceuticals has approved the lifting of ban on Export of Hydroxychloroquine API as well as formulations," India's minister for chemicals and fertilizers, Sadananda Gowda, said on Twitter.

  • Coronavirus pandemic | No benefit of hydroxychloroquine in COVID-19 cases: Oxford University trial Jun 06, 2020 03:52 PM IST

    Coronavirus pandemic | No benefit of hydroxychloroquine in COVID-19 cases: Oxford University trial

    Researchers found "no significant difference" in mortality rate after 28 days of administering HCQ to Covid-19 patients.

  • WHO continues hydroxychloroquine trial after UK test halts Jun 05, 2020 10:55 PM IST

    WHO continues hydroxychloroquine trial after UK test halts

    "There are two distinct trials with their own protocols, their own oversight committees. Therefore we will continue for now," Soumya Swaminathan, the WHO's chief scientist, told an online news briefing when asked about the British trial halt.

  • Coronavirus pandemic | WHO's decision to suspend HCQ trial was a knee-jerk reaction: CSIR chief Jun 05, 2020 07:18 PM IST

    Coronavirus pandemic | WHO's decision to suspend HCQ trial was a knee-jerk reaction: CSIR chief

    The World Health Organization had suspended the hydroxychloroquine (HCQ) arm of the clinical trials of experimental COVID-19 drugs over safety concerns

  • Controversial Lancet study linking hydroxychloroquine, deaths in COVID-19 treatment retracted Jun 05, 2020 11:10 AM IST

    Controversial Lancet study linking hydroxychloroquine, deaths in COVID-19 treatment retracted

    "Several concerns were raised with respect to the veracity of the data and analyses conducted by Surgisphere Corporation and its founder and our co-author, Sapan Desai, in our publication," the authors of the study wrote in the retraction statement published in The Lancet journal.

  • WHO's decision to resume HCQ clinical trial a step in right direction, say experts Jun 04, 2020 05:45 PM IST

    WHO's decision to resume HCQ clinical trial a step in right direction, say experts

    The global heath body had earlier suspended the hydroxychloroquine (HCQ) arm of the clinical trials of experimental COVID-19 drugs over safety concerns. However on Wednesday, it recommended the trial to be continued following a review of safety data.

  • Lancet issues 'expression of concern' after scientists question validity of HCQ study Jun 04, 2020 04:25 PM IST

    Lancet issues 'expression of concern' after scientists question validity of HCQ study

    "We are issuing an Expression of Concern to alert readers to the fact that serious scientific questions have been brought to our attention. We will update this notice as soon as we have further information," the editors of the journal said.

  • COVID-19 treatment | Hydroxychloroquine no better than placebo, new study finds Jun 04, 2020 08:58 AM IST

    COVID-19 treatment | Hydroxychloroquine no better than placebo, new study finds

    Researchers conducted a randomised, double-blind, placebo-controlled trial across the United States and Canada to test Hydroxychloroquine as a post-exposure prophylaxis.

  • US hospitals slash use of drug championed by Donald Trump as coronavirus treatment May 29, 2020 04:10 PM IST

    US hospitals slash use of drug championed by Donald Trump as coronavirus treatment

    Early hopes for the decades-old drug were based in part on laboratory experiments and its anti-inflammatory and antiviral properties. But its efficacy has so far failed to pan out in human trials, and at least two studies suggest it may increase the risk of death.

  • Donald Trump feeling 'absolutely great' after taking hydroxychloroquine: White House May 29, 2020 08:04 AM IST

    Donald Trump feeling 'absolutely great' after taking hydroxychloroquine: White House

    Hydroxychloroquine sulfate was first synthesised in 1946 and is in a class of medications historically used to treat and prevent malaria. It is approved by the US Food and Drug Administration to treat malaria, rheumatoid arthritis, lupus, childhood arthritis, and other autoimmune diseases.

  • Hydroxychloroquine combination risky for cancer patients with COVID-19: Study May 29, 2020 07:36 AM IST

    Hydroxychloroquine combination risky for cancer patients with COVID-19: Study

    The preliminary results suggest doctors may want to refrain from prescribing the decades-old malaria treatment hydroxychloroquine with the antibiotic azithromycin for these patients until more study is done, researchers said.

  • Mixed opinion by Indian experts on WHO's temporary pause on hydroxychloroquine trial May 26, 2020 05:55 PM IST

    Mixed opinion by Indian experts on WHO's temporary pause on hydroxychloroquine trial

    While some experts feel that after the WHO decisions, country's medical centres will have to take HCQ and chloroquine our of the treatment regimen of COVID-19 patients, others opined it is "not binding" for India to oblige with the decision of the world body.

  • UN coronavirus therapy trial pauses hydroxychloroquine testing May 26, 2020 12:44 PM IST

    UN coronavirus therapy trial pauses hydroxychloroquine testing

    The World Health Organization said Monday that it will temporarily drop hydroxychloroquine — the anti-malarial drug US President Trump says he is taking

  • WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns May 26, 2020 08:16 AM IST

    WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns

    Hydroxycholoroquine has been touted by Donald Trump and others as a possible treatment for the disease caused by the novel coronavirus. The U.S. President has said he was taking the drug to help prevent infection.

  • Touted by Donald Trump as COVID-19 treatment, HCQ tied to increased risk of death: Study May 22, 2020 07:48 PM IST

    Touted by Donald Trump as COVID-19 treatment, HCQ tied to increased risk of death: Study

    The authors said they could not confirm if taking the drug resulted in any benefit in coronavirus patients.

  • Coronavirus pandemic: Donald Trump says his hydroxychloroquine regimen finishes in 'day or two' May 21, 2020 11:35 AM IST

    Coronavirus pandemic: Donald Trump says his hydroxychloroquine regimen finishes in 'day or two'

    Trump disclosed on Tuesday that he was taking the drug despite medical warnings about potential serious side effects and questions about its effectiveness in preventing the coronavirus.

  • Hydroxychloroquine a 'line of defence' against virus, says Donald Trump defending drug May 20, 2020 07:21 AM IST

    Hydroxychloroquine a 'line of defence' against virus, says Donald Trump defending drug

    I'm just very curious myself, but it seems to be very safe,” Trump told reporters at the White House, a day after he disclosed that he has been taking the drug to ward off the deadly infection.

  • Donald Trump says he is taking hydroxychloroquine despite FDA warning May 19, 2020 10:05 AM IST

    Donald Trump says he is taking hydroxychloroquine despite FDA warning

    Trump volunteered the disclosure during a question-and-answer session with reporters at the White House as he met restaurant executives whose businesses are reeling from the impact of the virus.

Sections